Vicki DeArmon launched Foghorn Press and Sibylline Press, and has now written an “almost true” memoir of San Francisco’s flourishing indie press scene in the 1990s. Local author Vicki ...

Foghorn Therapeutics Inc. announced continued enrollment in its Phase 1 trial for FHD-909, a first-in-class oral selective SMARCA2 inhibitor targeting SMARCA4 mutated cancers, particularly non ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...